|[April 11, 2017]
Two Fire Rescue Departments Honored for Excellence in Emergency Medical Services
(NASDAQ: MASI) announced today that the Congressional Fire Services
Institute (CFSI) has honored the Orange (News - Alert) County (Florida) Fire
Rescue Department and the Montgomery County (Maryland) Fire & Rescue
Service with the Excellence in Fire Service-Based EMS Award for best
practices and innovative solutions in the delivery of emergency medical
services. The awards presentation took place on April 6th in
Washington, DC. Masimo is proud to be a co-sponsor of this award.
This Smart News Release features multimedia. View the full release here:
Orange County (Florida) Fire Rescue Department
The Orange County Fire Rescue Department was awarded the Excellence in
Fire Service-Based EMS Award in recognition of the development of two
best practices. The first is the Sepsis Alert Program, which educates
EMS providers to better identify potential cases of severe sepsis among
patients in pre-hospital settings, as early recognition and treatment
may improve patient outcomes and lessen the financial impact of
prolonged hospital stays. The program is modeled after similar "alert"
programs that trigger EMS responders to initiate certain procedures,
such as programs designed to recognize signs of stroke and cardiac
arrest. Preliminary results since establishing the Sepsis Alert Program
have included reductions in time to blood culture, time to administer
antibiotics, time to administer fluids, length of hospital stay, and
percentage admitted to the ICU.
The other best practice, the Paramedic Preceptor Academy, was developed
to increase pass rates for Orange County's new paramedics, as well as to
improve training and continuing education opportunities identified
through the department's quality assurance process. As a result of the
improved and standardized training, in the first year of the program
first-time pass rates on written and practical assessments have
increased dramatically. Several other central Florida fire departments
are now also participating in the Paramedic Preceptor Academy, in the
hopes of seeing similar results.
Montgomery County (Maryland) Fire & Rescue Service
The Montgomery County Fire & Rescue Service was awarded the Excellence
in Fire Service-Based EMS Award in recognition of the creation of an
outreach initiative called Montgomery County Non-Emergency Invention and
Community Care Coordination (MCNIC3). Montgomery County developed MCNIC3
to address the disparity between the volume of emergency 911 calls,
which continues to grow, and EMS resources, which have stayed relatively
flat. Much of the growth in 911 calls is a result of low-priority calls
from frequent 911 users. MCNIC3 targets these frequent 911 users and
attempts to connect them with a variety of community-based medical and
social programs, in an effort to better meet their ongoing healthcare
needs without taking emergency care away from those with true emergency
needs. Firefighters and EMS providers are able to refer any patient they
encounter to the MCNIC3 program. By partnering with local hospitals, the
health department, and various community groups, MCNIC3 can arrange
periodic in-person visits to ensure that the patients' healthcare needs
are being met without straining county resources. To date, MCNIC3 has
reduced calls for emergency service from those patients enrolled in the
program by 55%. There are plans to expand the scope of the program and
develop additional community partnerships.
"CFSI takes great�pride in co-sponsoring the Excellence in Fire
Service-Based EMS Awards with Masimo," said Dr. William F. Jenaway,
Ph.D., President of CFSI. "Through this awards program, we are able to
recognize innovations in the delivery of emergency medical services
throughout the nation. The recipients of the 2017 award, Orange and
Montgomery Counties, certainly demonstrated themselves worthy of this
recognition by developing outstanding new programs that improve
training, distribute resources more wisely, and ultimately improve
patient outcomes. We hope other departments around the country will be
inspired to introduce similar innovations."
"Firefighters and emergency services personnel are our heroes. In saving
lives, they put their own on the line for us every day. It's crucial
they have the training and resources they need to provide the best care
for those they protect. Recognizing the possibility of and intervening
to address sepsis as soon as possible, or example, can significantly
improve patient outcomes," said Joe Kiani, Founder and CEO of Masimo.
"Masimo is honored to co-sponsor this awards program with CFSI and to
recognize Orange and Montgomery Counties for their innovative
Approximately 1,600 fire and emergency services leaders attended the 29th
Annual National Fire and Emergency Services Dinner to pay tribute to the
dedication and commitment of the nation's fire and emergency services
providers. Hosted by CFSI, the annual dinner benefits the mission of the
non-profit policy organization, which is designed to educate members of
Congress about fire and life safety issues. This year's honored speakers
were four co-chairs of the Congressional Fire Services Caucus: Senator
Susan Collins (ME), Senator Tom Carper (DE), Congressman Steny Hoyer
(MD05) and Congressman Bill Pascrell (NJ09).
The Excellence in Fire Service-Based EMS Awards Program was established
in 2010 to recognize volunteer, career, and combination fire departments
for excellence in and enhancements to the delivery of emergency medical
services. By showcasing their best practices, the awards program
provides ideas for other fire departments to consider implementing as
they seek to improve their fire service-based EMS systems.
Masimo (NASDAQ: MASI) is a global leader in
innovative noninvasive monitoring technologies. Our mission is to
improve patient outcomes and reduce the cost of care by taking
noninvasive monitoring to new sites and applications. In 1995, the
company debuted Masimo SET® Measure-through Motion and Low
Perfusion™ pulse oximetry, which has been shown in multiple studies to
significantly reduce false alarms and accurately monitor for true
alarms. Masimo SET® has also been shown to help clinicians
reduce severe retinopathy of prematurity in neonates,1
improve CCHD screening in newborns,2 and, when used for
continuous monitoring with Masimo Patient SafetyNet™* in post-surgical
wards, reduce rapid response activations and costs.3,4,5
Masimo SET® is estimated to be used on more than 100 million
patients in leading hospitals and other healthcare settings around the
world,6 including 9 of the top 10 hospitals listed in the
2016-17 U.S. News and World Report Best Hospitals Honor Roll.7
In 2005, Masimo introduced rainbow® Pulse (News - Alert) CO-Oximetry
technology, allowing noninvasive and continuous monitoring of blood
constituents that previously could only be measured invasively,
including total hemoglobin (SpHb®), oxygen content (SpOC™),
carboxyhemoglobin (SpCO®), methemoglobin (SpMet®),
and more recently, Pleth Variability Index (PVi®) and Oxygen
Reserve Index (ORi™), in addition to SpO2, pulse rate, and
perfusion index (PI). In studies with SpHb, reductions in blood
transfusion** were observed8,9 and when used with
PVi, a reduction in 30-day mortality was observed.10 In 2014,
Masimo introduced Root®, an intuitive patient monitoring and
connectivity platform with the Masimo Open Connect™ (MOC-9™) interface,
enabling other companies to augment Root with new features and
measurement capabilities. Masimo is also taking an active leadership
role in mHealth with products such as the Radius-7™ wearable patient
monitor, iSpO2® pulse oximeter for smartphones,
and the MightySat™ fingertip pulse oximeter. Additional information
about Masimo and its products may be found at www.masimo.com.
All published clinical studies on Masimo products can be found at http://www.masimo.com/cpub/clinical-evidence.htm.
*The use of the trademark Patient SafetyNet is under license from
University HealthSystem Consortium.
**Clinical decisions regarding red blood cell transfusions should be
based on the clinician's judgment considering, among other factors:
patient condition, continuous SpHb monitoring, and laboratory diagnostic
tests using blood samples.
Castillo A et al. Prevention of Retinopathy of Prematurity in Preterm
Infants through Changes in Clinical Practice and SpO2
Technology. Acta Paediatr. 2011 Feb;100(2):188-92.
de-Wahl Granelli A et al. Impact of pulse oximetry screening on the
detection of duct dependent congenital heart disease: a Swedish
prospective screening study in 39,821 newborns. BMJ. 2009;338.
Taenzer AH et al. Impact of Pulse Oximetry Surveillance on Rescue
Events and Intensive Care Unit Transfers: A Before-And-After
Concurrence Study. Anesthesiology. 2010; 112(2):282-287.
Taenzer AH et al. Postoperative Monitoring - The Dartmouth Experience. Anesthesia
Patient Safety Foundation Newsletter. Spring-Summer 2012.
McGrath SP et al. Surveillance Monitoring Management for General Care
Units: Strategy, Design, and Implementation. The Joint Commission
Journal on Quality and Patient Safety. 2016 Jul;42(7):293-302.
Estimate: Masimo data on file.
Ehrenfeld JM et al. Continuous Non-invasive Hemoglobin Monitoring
during Orthopedic Surgery: A Randomized Trial. J Blood Disorders
Transf. 2014. 5:9. 2.
Awada WN et al. Continuous and noninvasive hemoglobin monitoring
reduces red blood cell transfusion during neurosurgery: a prospective
cohort study. J Clin Monit Comput. 2015 Feb 4.
Nathan N et al. Impact of Continuous Perioperative SpHb Monitoring.
Proceedings from the 2016 ASA Annual Meeting, Chicago. Abstract #A1103.
This press release includes
forward-looking statements as defined in Section 27A of the Securities
Act of 1933 and Section 21E of the Securities Exchange Act of 1934, in
connection with the Private Securities Litigation Reform Act of 1995.
These forward-looking statements are based on current expectations about
future events affecting us and are subject to risks and uncertainties,
all of which are difficult to predict and many of which are beyond our
control and could cause our actual results to differ materially and
adversely from those expressed in our forward-looking statements as a
result of various risk factors, including, but not limited to: risks
related to our assumptions regarding the repeatability of clinical
results; risks related to our belief that Masimo's unique noninvasive
measurement technologies contribute to positive clinical outcomes and
patient safety; as well as other factors discussed in the "Risk Factors"
section of our most recent reports filed with the Securities and
Exchange Commission ("SEC (News - Alert)"), which may be obtained for free at the SEC's
website at www.sec.gov.
Although we believe that the expectations reflected in our
forward-looking statements are reasonable, we do not know whether our
expectations will prove correct. All forward-looking statements included
in this press release are expressly qualified in their entirety by the
foregoing cautionary statements. You are cautioned not to place undue
reliance on these forward-looking statements, which speak only as of
today's date. We do not undertake any obligation to update, amend or
clarify these statements or the "Risk Factors" contained in our most
recent reports filed with the SEC, whether as a result of new
information, future events or otherwise, except as may be required under
the applicable securities laws.
View source version on businesswire.com: http://www.businesswire.com/news/home/20170411005664/en/
[ InfoTech Spotlight's Homepage ]